Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 In vivo studies with hexamethylmelamine.

× No keyword cloud information.

13 in total

1. Preclinical toxicology, pharmacokinetics and formulation of N2,N4,N6-trihydroxymethyl-N2,N4,N6-trimethylmelamine (trimelamol), a water-soluble cytotoxic s-triazine which does not require metabolic activation.

Authors: C J Rutty; I R Judson; G Abel; P M Goddard; D R Newell; K R Harrap
Journal: Cancer Chemother Pharmacol Date: 1986 Impact factor: 3.333

2. The comparative pharmacokinetics of pentamethylmelamine in man, rat, and mouse.

Authors: C J Rutty; D R Newell; J R Muindi; K R Harrap
Journal: Cancer Chemother Pharmacol Date: 1982 Impact factor: 3.333

3. Altretamine for the treatment of metastatic renal cell carcinoma. A Hoosier Oncology Group trial.

Authors: R T Zon; J McClean; D Helman; R Ansari; J Picus; A Sandler; S D Williams; P J Loehrer
Journal: Invest New Drugs Date: 2001 Impact factor: 3.850

Review 4. Altretamine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cancer chemotherapy.

Authors: C R Lee; D Faulds
Journal: Drugs Date: 1995-06 Impact factor: 9.546

Review 5. N-methyl antitumour agents. A distinct class of anticancer drugs?

Authors: D Newell; A Gescher; S Harland; D Ross; C Rutty
Journal: Cancer Chemother Pharmacol Date: 1987 Impact factor: 3.333

6. Pharmacokinetics and metabolism of hexamethylmelamine in mice bearing renal cell tumors.

Authors: J Dubois; G Atassi; M Hanocq; F Abikhalil
Journal: Cancer Chemother Pharmacol Date: 1988 Impact factor: 3.333

7. Effect of a hepatic activation system on the antiproliferative activity of hexamethylmelamine against human tumor cell lines.

Authors: K J Miller; R M McGovern; M M Ames
Journal: Cancer Chemother Pharmacol Date: 1985 Impact factor: 3.333

In vivo studies with hexamethylmelamine.